This global role will lead the medical evidence strategy for the RSV adult vaccines asset, focusing on vaccine effectiveness and burden studies, with a worldwide focus including support for Asia.
Base: $230,900.00 - $384,800.00; Bonus/Equity: 25.0% bonus target, share-based long term incentive; Benefits: 401(k) with match, retirement savings, paid time off, medical, dental, vision
Must-have
Nice-to-have
Permanent work authorization required